Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

On the integration of alcohol-related quantitative trait loci and gene expression analyses.

Hitzemann R, Reed C, Malmanger B, Lawler M, Hitzemann B, Cunningham B, McWeeney S, Belknap J, Harrington C, Buck K, Phillips T, Crabbe J.

Alcohol Clin Exp Res. 2004 Oct;28(10):1437-48. Erratum in: Alcohol Clin Exp Res. 2004 Dec;28(12):1930.

PMID:
15597075
2.

A strategy for the integration of QTL, gene expression, and sequence analyses.

Hitzemann R, Malmanger B, Reed C, Lawler M, Hitzemann B, Coulombe S, Buck K, Rademacher B, Walter N, Polyakov Y, Sikela J, Gensler B, Burgers S, Williams RW, Manly K, Flint J, Talbot C.

Mamm Genome. 2003 Nov;14(11):733-47.

PMID:
14722723
3.
5.

Ethanol-induced expression of c-Fos differentiates the FAST and SLOW selected lines of mice.

Demarest K, Hitzemann B, Phillips T, Hitzemann R.

Alcohol Clin Exp Res. 1999 Jan;23(1):87-95.

PMID:
10029207
6.

Further evidence that the central nucleus of the amygdala is associated with the ethanol-induced locomotor response.

Demarest K, Hitzemann B, Mahjubi E, McCaughran J Jr, Hitzemann R.

Alcohol Clin Exp Res. 1998 Oct;22(7):1531-7.

PMID:
9802539
7.
8.

Genetics ethanol and the Fos response: a comparison of the C57BL/6J and DBA/2J inbred mouse strains.

Hitzemann B, Hitzemann R.

Alcohol Clin Exp Res. 1997 Nov;21(8):1497-507.

PMID:
9394124
9.

Genetics, neuroleptic response and the organization of cholinergic neurons in the mouse striatum.

Dains K, Hitzemann B, Hitzemann R.

J Pharmacol Exp Ther. 1996 Dec;279(3):1430-8.

PMID:
8968368
10.

Mapping the genes for haloperidol-induced catalepsy.

Kanes S, Dains K, Cipp L, Gatley J, Hitzemann B, Rasmussen E, Sanderson S, Silverman M, Hitzemann R.

J Pharmacol Exp Ther. 1996 May;277(2):1016-25.

PMID:
8627512
11.

Genetics and the organization of the basal ganglia.

Hitzemann R, Qian Y, Kanes S, Dains K, Hitzemann B.

Int Rev Neurobiol. 1995;38:43-94. Review. No abstract available.

PMID:
8537205
12.

Further studies on the relationship between dopamine cell density and haloperidol-induced catalepsy.

Hitzemann B, Dains K, Kanes S, Hitzemann R.

J Pharmacol Exp Ther. 1994 Nov;271(2):969-76.

PMID:
7965819
13.

D1 and D2 dopamine receptor turnover and D2 messenger RNA levels in the neuroleptic-responsive and the neuroleptic nonresponsive lines of mice.

Qian Y, Hitzemann B, Yount GL, White JD, Hitzemann R.

J Pharmacol Exp Ther. 1993 Dec;267(3):1582-90.

PMID:
7903394
14.

On the relationship between D2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice.

Kanes SJ, Hitzemann BA, Hitzemann RJ.

J Pharmacol Exp Ther. 1993 Oct;267(1):538-47.

PMID:
7901398
15.
17.

Repeated electroconvulsive shock: effect on sodium dependency and regional distribution of opioid-binding sites.

Hitzemann RJ, Hitzemann BA, Blatt S, Meyerhoff JL, Tortella FC, Kenner JR, Belenky GL, Holaday JW.

Mol Pharmacol. 1987 May;31(5):562-6.

PMID:
3033470
18.

Determination of chlorpromazine and its major metabolites by gas chromatography/mass spectrometry: application to biological fluids.

Gruenke LD, Craig JC, Klein FD, Nguyen TL, Hitzemann BA, Holaday JW, Loh HH, Braff L, Fischer A, Glick ID, et al.

Biomed Mass Spectrom. 1985 Dec;12(12):707-13.

PMID:
2936401
19.

The prolactin response in schizophrenic, schizophreniform, and manic disorders.

Hitzemann R, Hirschowitz J, Hitzemann B, Garver D.

Biol Psychiatry. 1984 Jun;19(6):913-8. No abstract available.

PMID:
6743725
20.

Platelet monoamine oxidase activity in the psychoses: relationship to symptoms and lithium response.

Hitzemann RJ, Sautter F, Hitzemann B, Hirschowitz J, Garver DL.

Psychiatry Res. 1984 Mar;11(3):211-21.

PMID:
6587414
21.

On the relation between platelet monoamine oxidase activity and the growth hormone response in psychosis.

Hitzemann R, Hirschowitz J, Zemlan F, Hitzemann B, Garver D.

Biol Psychiatry. 1983 Dec;18(12):1503-7. No abstract available.

PMID:
6661478
22.

Effect of free fatty acids (FFA) on platelet serotonin (5-HT) release in normals and migraineurs.

Hitzemann R, Hitzemann B, Oxman T, Smith R.

Proc West Pharmacol Soc. 1983;26:281-5. No abstract available.

PMID:
6889355
23.

Phosphatidate as a molecular link between depolarization and neurotransmitter release in the brain.

Harris RA, Schmidt J, Hitzemann BA, Hitzemann RJ.

Science. 1981 Jun 12;212(4500):1290-1.

PMID:
7233220
24.

Effect of pentobarbital on regional brain phospholipid synthesis.

Natsuki R, Hitzemann RJ, Hitzemann BA, Loh HH.

Biochem Pharmacol. 1977 Nov 15;26(22):2095-100. No abstract available.

PMID:
588290
25.

Effects of withdrawal from chronic amphetamine intoxication on exploratory and stereotyped behaviors in the rat.

Hitzemann RJ, Tseng LF, Hitzemann BA, Sampath-Khanna S, Loh HH.

Psychopharmacology (Berl). 1977 Nov 15;54(3):295-302.

PMID:
413148
26.

Influence of prenatal d-amphetamine administration on development and behavior of rats.

Hitzemann BA, Hitzemann RJ, Brase DA, Loh HH.

Life Sci. 1976 Mar 15;18(6):605-12. No abstract available.

PMID:
1263744
27.

On the specificity of trypsin (EC 3.4.4.4) of nerve ending particles to inhibit norepinephrine transport.

Hitzemann BA, Hitzemann RJ, Loh HH.

J Neurochem. 1975 Feb;24(2):323-30. No abstract available.

PMID:
1113109
28.

Binding of 3H-naloxone in the mouse brain: effect of ions and tolerance development.

Hitzemann RJ, Hitzemann BA, Loh HH.

Life Sci. 1974 Jun 16;14(12):2393-404. No abstract available.

PMID:
4549965

Supplemental Content

Loading ...
Support Center